{"id":"W4407121640","doi":"10.1016/s0140-6736(25)00161-8","title":"First phase 3 trial of GLP-1 receptor agonist for neurodegeneration","year":2025,"lang":"en","type":"letter","venue":"The Lancet","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Agonist; Neurodegeneration; Medicine; Neuroscience; Pharmacology; Receptor; Internal medicine; Biology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003287246,0.0008839546,0.00156242,0.0004510864,0.001500595,0.002422879,0.00130003,0.0278944,0.007987662],"category_scores_gemma":[0.01053029,0.0004480157,0.001616434,0.000379151,0.00142615,0.001569907,0.0007124525,0.01808778,0.004945672],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003478277,"about_ca_system_score_gemma":0.002760016,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003565803,"about_ca_topic_score_gemma":0.01177973,"domain_scores_codex":[0.9980168,0.000736037,0.0001654171,0.0002138597,0.0005215114,0.0003464886],"domain_scores_gemma":[0.9949582,0.0029277,0.0002981222,0.0001271449,0.0004749885,0.001213744],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.003328579,0.0002133179,0.0007520121,0.0001388137,0.0001340382,0.001680816,0.00004808003,0.0001498649,0.0006482113,0.003295892,0.9533485,0.03626181],"study_design_scores_gemma":[0.01639012,0.002025478,0.003217308,0.0007045284,0.0003715995,0.001747463,0.0001825927,0.00159905,0.001285223,0.02267096,0.9497117,0.00009392542],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.002005587,0.004713932,0.0002738364,0.9463164,0.03436721,0.0000697835,0.0005232805,0.00005554936,0.01167455],"genre_scores_gemma":[0.01438845,0.001709334,0.0004639869,0.927783,0.04005594,0.0001495635,0.0002546394,0.00003959382,0.0151556],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.0278944,"threshold_uncertainty_score":0.02672136,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04692468544127923,"score_gpt":0.3130679863088689,"score_spread":0.2661433008675896,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}